NO921723L - Nye kinolinforbindelser, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse - Google Patents

Nye kinolinforbindelser, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse

Info

Publication number
NO921723L
NO921723L NO92921723A NO921723A NO921723L NO 921723 L NO921723 L NO 921723L NO 92921723 A NO92921723 A NO 92921723A NO 921723 A NO921723 A NO 921723A NO 921723 L NO921723 L NO 921723L
Authority
NO
Norway
Prior art keywords
preparation
procedure
new
therapeutic use
quinol compounds
Prior art date
Application number
NO92921723A
Other languages
English (en)
Norwegian (no)
Other versions
NO921723D0 (no
Inventor
Peter Gull
Rudolf Markstein
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO921723D0 publication Critical patent/NO921723D0/no
Publication of NO921723L publication Critical patent/NO921723L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO92921723A 1991-05-02 1992-04-30 Nye kinolinforbindelser, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse NO921723L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4114325A DE4114325A1 (de) 1991-05-02 1991-05-02 Octahydrobenzo(g)chinolin, seine herstellung und verwendung

Publications (2)

Publication Number Publication Date
NO921723D0 NO921723D0 (no) 1992-04-30
NO921723L true NO921723L (no) 1992-11-03

Family

ID=6430818

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921723A NO921723L (no) 1991-05-02 1992-04-30 Nye kinolinforbindelser, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse

Country Status (18)

Country Link
EP (1) EP0512952A1 (cs)
JP (1) JPH05170762A (cs)
KR (1) KR920021533A (cs)
AU (1) AU656768B2 (cs)
CA (1) CA2067648A1 (cs)
CS (1) CS131192A3 (cs)
DE (1) DE4114325A1 (cs)
FI (1) FI921957L (cs)
HU (1) HUT61011A (cs)
IE (1) IE921374A1 (cs)
IL (1) IL101735A0 (cs)
MX (1) MX9202024A (cs)
MY (1) MY131278A (cs)
NO (1) NO921723L (cs)
NZ (1) NZ242562A (cs)
RO (1) RO109333B1 (cs)
TW (1) TW241262B (cs)
ZA (1) ZA923187B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them
SE0001438D0 (sv) 2000-04-18 2000-04-18 Axon Chemicals Bv New chemical compounds and their use in therapy
PE20030240A1 (es) * 2001-07-09 2003-04-16 Novartis Ag DERIVADOS DE BENZO [g] QUINOLINA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3280252D1 (de) * 1981-10-16 1990-10-31 Sandoz Ag 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)chinolin-derivate mit pharmazeutischer wirkung.
PH22782A (en) * 1983-02-01 1988-12-12 Sandoz Ltd Novel pharmaceutical active 1,2,3,4,4a,5,10,10a octahydrobenzo(g)quinoline derivatives

Also Published As

Publication number Publication date
FI921957A7 (fi) 1992-11-03
KR920021533A (ko) 1992-12-18
MY131278A (en) 2007-07-31
AU656768B2 (en) 1995-02-16
JPH05170762A (ja) 1993-07-09
IL101735A0 (en) 1992-12-30
HU9201296D0 (en) 1992-07-28
EP0512952A1 (de) 1992-11-11
HUT61011A (en) 1992-11-30
FI921957L (fi) 1992-11-03
AU1529192A (en) 1992-11-05
IE921374A1 (en) 1992-11-04
DE4114325A1 (de) 1992-11-05
CS131192A3 (en) 1992-11-18
MX9202024A (es) 1992-11-01
NZ242562A (en) 1994-08-26
NO921723D0 (no) 1992-04-30
ZA923187B (en) 1993-11-01
FI921957A0 (fi) 1992-04-30
CA2067648A1 (en) 1992-11-03
TW241262B (cs) 1995-02-21
RO109333B1 (ro) 1995-01-30

Similar Documents

Publication Publication Date Title
NO904839L (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
SE0202462D0 (sv) Novel use
NO882036D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske ketoner.
NO173139C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-aminopyrimidinonderivater
SE0202429D0 (sv) Novel Compounds
CA2059103A1 (en) Process for the preparation of (6s)- and (6r)-tetrahydrofolates
NO166938C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoxyeddiksyrederivater.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE3855520D1 (de) Methode zur Verbesserung des Schlafes
DE3462894D1 (de) 3-indolecarboxamide compounds
NO921723L (no) Nye kinolinforbindelser, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse
NO914071L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
ES2001774A6 (es) Procedimiento para la preparacion de nuevos pirrolo-bencimidazoles, pirrolo-benzoxazoles y pirrolo-benzotiazoles.
NO902439L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
DK102788D0 (da) Quinolinforbindelse og dens farmaceutiske anvendelse
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
NO840526L (no) Derivater av n-iminopyridiniumbetainer, fremgangsmaate til deres fremstilling og deres anvendelse i medikamenter
ATE53209T1 (de) Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung.
ES8308559A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina.
ATE121623T1 (de) Verwendung von quinazolinen zur herstellung eines arzneimittels zur behandlung und vorbeugung von arrhythmie.
ES8205804A1 (es) Un procedimiento para la preparacio,n de nuevos derivados de denzopirano 2,3-d-v-triazol.
NO820701L (no) Fremgangsmaate for fremstilling av 1-(1,3-benzodioksol-5-yl)-2-pyrrolidinon.
ATE95697T1 (de) Uricosuretische zusammensetzung.
DK183385A (da) Apovincaminolderivater eller syreadditionssalte deraf, deres fremstilling og anvendelser som farmaceutika
EP0323189A3 (en) Optically active benzoquinolizine compounds, process for preparing same, and antibacterial preparation containing same as active ingredient